search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
DECONTAMINATION & STERILISATION ‘‘


The researchers examined 24 clinically used bronchoscopes. After manual cleaning, 100% of bronchoscopes had residual contamination


published in Chest, by Ofstead et al (2018).9


This study involved direct


observation of reprocessing methods for flexible bronchoscopes, multifaceted evaluations performed after manual cleaning and after high-level disinfection, and assessments of storage conditions.


Visual inspections


Visual inspections of ports and channels were performed using lighted magnification and borescopes, and contamination was detected using microbial cultures and tests for protein, haemoglobin, and adenosine triphosphate (ATP). Researchers assessed reprocessing practices, and storage cabinet cleanliness was evaluated by visual inspection and ATP tests. The researchers examined 24 clinically used bronchoscopes. After manual cleaning, 100% of bronchoscopes had residual contamination. Microbial growth was found in 14 fully reprocessed bronchoscopes (58%), including mould, Stenotrophomonas maltophilia, and Escherichia coli/Shigella species. Visible irregularities were observed in 100% of bronchoscopes, including retained fluid; brown, red, or oily residue; scratches; damaged insertion tubes and distal ends, and filamentous debris in channels.


Inadequate reprocessing practices Ofstead et al concluded that damaged and contaminated bronchoscopes were in use at all sites, and commented that inadequate reprocessing practices may have contributed to bioburden found on bronchoscopes. Two of the three study sites failed completely to observe routine reprocessing guidelines, while further issues were identified around disengaging an automated cleaning cycle. The study also uncovered sub-optimal bronchoscope storage practices and substandard routine maintenance of EWDs/AERs. However, even when guidelines were followed, high-level disinfection was not always effective. The authors suggested that a shift towards the use of sterilised bronchoscopes should be recommended. However, in the meantime, “quality management programmes and updated reprocessing guidelines were needed”. In the UK, MHRA and Department of Health HTM 01-06 guidance have also sought to address the issue of infection transmission via endoscopes. An incident reported from Northern Ireland, in 2004, uncovered inappropriate


decontamination practices, following a ‘look-back’ exercise. This prompted the MHRA to issue MDA/2004/028 – ‘Flexible


and rigid endoscopes’, which required Trusts to carry out an immediate assessment of all endoscope decontamination processes.


An Endoscope Task Force was set up in England to look into the decontamination of flexible endoscopes, and this classified problems into: n There were incompatibilities between endoscope and the EWD.


n Endoscopy staff were unfamiliar with the decontamination process specific to the particular endoscope.


n Communication between endoscope manufacturers and EWD manufacturers was poor.


which have since been revised and updated in the Department of Health’s HTM 01-06. These include: n Compatibility: Ensure compatibility with the existing decontamination processes, including the EWD, when purchasing any new endoscopes.


In response to these efforts, the MHRA issued its “Top Ten Tips” in October 2005,10


n Instructions: Ensure that all equipment is operated and controlled in accordance with the manufacturer’s instructions, local endoscope decontamination policy, and associated risk assessments.


n Track and trace: Auto-identification and associated data capture should be used to track and trace all endoscopes, reusable accessories, and EWDs, to ensure appropriate maintenance, correct decontamination, and traceability to associated patients.


n Lumen connection: Check that all lumens in each endoscope can be connected to the EWD using the correct connectors/connection sets provided.


n Manual cleaning: Ensure that endoscopes and reusable accessories are manually cleaned immediately after use, including the flushing of all lumens – even if they have not been used during the procedure.


n Chemical compatibility: Only use chemicals that are compatible with the endoscope and its reusable accessories, and observe the correct process parameters that have been validated and demonstrated to be effective.


n Essential Quality Requirements and Best Practice: Endoscopes should always be decontaminated and maintained to a level specified in Essential Quality Requirements. A continuous process of evaluation and improvement should be in place to progress towards locally determined best practice.


n Planned preventative maintenance: Have planned preventative maintenance and associated record- keeping in place to ensure all parts of the endoscope decontamination and management systems are optimally effective.


n Staff training: Ensure all staff, including new appointees, involved in the decontamination process are specifically trained in their role, and in the broad context of endoscope management, decontamination, and recontamination prevention, and that this training is kept up-to-date.


n Incident reporting: Report any potential failure in the management and decontamination of endoscopes, including equipment problems relating to endoscopes, EWDs, or process chemicals, to a line manager.


An assessment should also be carried out before endoscopy to identify patients with, or at increased risk of, CJD or vCJD. Trusts should aim to minimise the risks associated with prion contamination by closely following the Department of Health’s HTM 01-06 guidance on decontamination of endoscopes. This has been updated to take account of changes to the Advisory Committee on Dangerous Pathogens’ Transmissible Spongiform Encephalopathy (ACDP TSE) Subgroup’s general principles of decontamination (Annex C).


Bedside cleaning


Important changes include a focus on the need for bedside cleaning immediately after the procedure. After manually cleaning according to the manufacturer’s recommendations, the scope should also be passed through an endoscope washer-disinfector as soon as possible after use.


The updated HTM-01-06 guidance11 also


places increased emphasis on testing regimes, taking on board the Advisory Committee’s recommendation that: “A routine test for washer-disinfectors could be developed to measure the cleaning efficacy at validation and routine testing, such as daily or weekly tests. This method could be based on a process challenge device system that will monitor the optimised wash cycles; the results must be quantifiable and objective.” This update focuses on improving the washing and cleaning process, reducing the time from patient use to the decontamination process, and monitoring the cleaning efficacy of endoscope washer-disinfectors.


It is also important to point out that the Advisory Committee’s Annex C deprecates the use of Ninhydrin in the detection of protein levels because of its insensitivity.


The Department of Health states that October 2019 Health Estate Journal 97


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160